Skip to main content
. Author manuscript; available in PMC: 2021 Aug 1.
Published in final edited form as: Gynecol Oncol. 2020 Jun 8;158(2):366–374. doi: 10.1016/j.ygyno.2020.05.025

Table 1.

Adjusted Means (95% Confidence Interval) of Female Sexual Function Index Outcomes over Time

Total Score Desire Arousal Lubrication Orgasm Satisfaction Pain
Mean*
95% CI
P value**
Mean*
95% CI
P value**
Mean*
95% CI
P value**
Mean*
95% CI
P value**
Mean*
95% CI
P value**
Mean*
95% CI
P value**
Mean*
95% CI
P value**
BL 11.43
(8.71, 14.14)
2.61
(2.25, 2.97)
1.72
(1.14, 2.3)
1.41
(0.85, 1.96)
1.76
(1.11, 2.4)
2.59
(2.06, 3.12)
1.5
(0.87, 2.13)
T2 13.71
(10.8, 16.57)
0.0424
2.92
(2.53, 3.31)
0.1012
2.32
(1.71, 2.94)
0.0226
2
(1.41, 2.6)
0.0215
2.4
(1.72, 3.09)
0.0297
2.8 6
(2.3, 3.42)
0.3083
1.49
(0.83, 2.16)
0.9825
T3 13.51
(10.6, 16.43)
0.0714
2.85
(2.45, 3.25)
0.2133
2.32
(1.7, 2.95)
0.0249
1.72
(1.12, 2.32)
0.2251
2.22
(1.52, 2.91)
0.1263
3.0 2
(2.44, 3.59)
0.1265
1.74
(1.06, 2.42)
0.4336
T4 14.14
(11.11, 17.17)
0.0283
3.2
(2.78, 3.63)
0.0048
2.2 8
(1.63, 2.93)
0.0488
2.1
(1.47, 2.73)
0.0139
2.39
(1.67, 3.12)
0.0475
2.49
(1.87, 3.11)
0.7443
2.01
(1.3, 2.72)
0.1177
*

Means are from linear mixed models adjusting for time point, months since treatment completion, and age. The endpoint marginal means were calculated from these models for each time point holding the other variables constant at their sample means.

**

P values are from tests of differences between the baseline mean and each of the follow-up means.

CI, Confidence Interval; BL, Baseline; T2, Timepoint 2; T3, Timepoint 3; T4, Timepoint 4; FSFI, Female Sexual Function Index

HHS Vulnerability Disclosure